个性化文献订阅>期刊> Oncogene
 

A gene expression signature classifying telomerase and ALT immortalization reveals an hTERT regulatory network and suggests a mesenchymal stem cell origin for ALT

  作者 Lafferty-Whyte, K; Cairney, CJ; Will, MB; Serakinci, N; Daidone, MG; Zaffaroni, N; Bilsland, A; Keith, WN  
  选自 期刊  Oncogene;  卷期  2009年28-43;  页码  3765-3774  
  关联知识点  
 

[摘要]Telomere length is maintained by two known mechanisms, the activation of telomerase or alternative lengthening of telomeres (ALT). The molecular mechanisms regulating the ALT phenotype are poorly understood and it is unknown how the decision of which pathway to activate is made at the cellular level. We have shown earlier that active repression of telomerase gene expression by chromatin remodelling of the promoters is one mechanism of regulation; however, other genes and signalling networks are likely to be required to regulate telomerase and maintain the ALT phenotype. Using gene expression profiling, we have uncovered a signature of 1305 genes to distinguish telomerase-positive and ALT cell lines. By combining this with the gene expression profiles of liposarcoma tissue samples, we refined this signature to 297 genes. A network analysis of known interactions between genes within this signature revealed a regulatory signalling network consistent with a model of human telomerase reverse transcriptase (hTERT) repression in ALT cell lines and liposarcomas. This network expands on our existing knowledge of hTERT regulation and provides a platform to understand differential regulation of hTERT in different tumour types and normal tissues. We also show evidence to suggest a novel mesenchymal stem cell origin for ALT immortalization in cell lines and mesenchymal tissues. Oncogene (2009) 28, 3765-3774; doi:10.1038/onc.2009.238; published online 17 August 2009

 
      被申请数(0)  
 

[全文传递流程]

一般上传文献全文的时限在1个工作日内